Cerebral Palsy (CP) is a permanent disorder of movement and posture caused by non-progressive disturbances in the developing foetal or infant brain. It is the most common motor disability in childhood, and its symptoms — spasticity, poor coordination, involuntary movements — can vary greatly from person to person.

‍What Cytotron Addresses in CP
‍RFQMR-FRB therapy stimulates neural progenitor cells and promotes regeneration of neural pathways in the brain. Clinical observations have shown improvements in motor function, reduced spasticity, and greater voluntary movement control. The therapy works by modulating cellular protein pathways to support the brain’s inherent regenerative mechanisms.

‍What Improvement Looks Like
‍Improvement varies by patient. Families have reported increased head control, improved ability to sit and stand, reduced involuntary movements, better coordination, and enhanced speech and swallowing function. Progress is typically assessed over a 6–12 month period following treatment, as the regenerative effects continue beyond the 28-day cycle.